SCHEMBL419916

SCHEMBL419916

CCOC(=O)OC(=O)c1ccc2c(c1)C(=O)c1ccccc1C2=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 9/20 0.61
▸ SMN1; SMN2 Q16637 6/20 0.53
▸ NPC1 O15118 6/20 0.53
▸ RAB9A P51151 6/20 0.53
▸ ALDH1A1 P00352 4/20 0.53
▸ LMNA P02545 3/20 0.53
▸ TTR P02766 2/20 0.51
▸ HTT P42858 2/20 0.49
▸ GABRP O00591 1/20 0.48
▸ GABRD O14764 1/20 0.48
▸ GABRA1 P14867 1/20 0.48
▸ GABRB1 P18505 1/20 0.48
▸ GABRG2 P18507 1/20 0.48
▸ GABRB3 P28472 1/20 0.48
▸ GABRA5 P31644 1/20 0.48
▸ GABRA3 P34903 1/20 0.48
▸ GABRA2 P47869 1/20 0.48
▸ GABRB2 P47870 1/20 0.48
▸ GABRA4 P48169 1/20 0.48
▸ GABRE P78334 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2268884 0.88 MAPT (0.75) MAPTSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL6933741 0.83 TTR (0.67) MAPTSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL6934221 0.81 TTR (0.65) MAPTSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL5846673 0.80 MAPT (0.68) MAPTSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL23051434 0.79 ALDH1A1 (0.64) MAPTSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL4919505 0.78 MAPT (0.62) MAPTSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL2265496 0.77 TTR (0.62) MAPTSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL9917228 0.77 MAPT (0.59) MAPTSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL10597544 0.77 KMT2A (0.49) MAPTSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL9666128 0.76 LMNA (0.56) MAPTSMN1; SMN2NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120095205-A1 Method of Modification of Hyaluronic Acid by Means of (O-ACYL-O'-ALKYL Carbonate-Substituted Pyridine) Complex CONTIPRO C (CZ) 2012-04-19 — — US disclosed
EP-2408823-A1 A METHOD OF MODIFICATION OF HYALURONIC ACID BY MEANS OF (O-ACYL-O'-ALKYL CARBONATE - SUBSTITUTED PYRIDINE) COMPLEX Contipro C A.S. (CZ) 2012-01-25 — — EP disclosed
WO-2010105582-A1 A METHOD OF MODIFICATION OF HYALURONIC ACID BY MEANS OF (O-ACYL-O'-ALKYL CARBONATE - SUBSTITUTED PYRIDINE) COMPLEX CONTIPRO C A.S. (CZ) 2010-09-23 — — WO disclosed
Send feedback